The topic of this article may not meet Wikipedia's
general notability guideline. Please help to demonstrate the notability of the topic by citing
reliable secondary sources that are
independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be
merged,
redirected, or
deleted. Find sources: "N1-Methyl-lysergic acid diethylamide" – news · newspapers · books · scholar · JSTOR (April 2015) ( Learn how and when to remove this message) |
Clinical data | |
---|---|
Other names | MLD-41; N1-Methyl-Lysergic Acid Diethylamide |
Routes of administration | Oral |
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C21H27N3O |
Molar mass | 337.467 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(verify) |
N1-Methyl-lysergic acid diethylamide (MLD-41) is a derivative of LSD that has about one-third the psychoactive effects. It has been studied in cross-tolerance of LSD. [1]
Metabolism of other 1-methylated-ergoloids to their secondary amine derivatives has been frequently noted in mammals. [2]
Lysergic acid derivatives |
|
---|---|
Psychedelic lysergamides |
|
Clavines | |
Other ergolines | |
Natural sources |
Morning glory: Argyreia nervosa (Hawaiian Baby Woodrose), Ipomoea spp.(Morning Glory, Tlitliltzin, Badoh Negro), Rivea corymbosa (Coaxihuitl, Ololiúqui) |
This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |